The Rentokil (LSE: RT)) share price has rocketed this morning (7 March) and as far as I’m concerned, that’s as welcome as a plague of rats.
Why so bitter? Because I’ve been desperate to buy the FTSE 100 pest control expert for months, having decided its shares had been unfairly treated by the market. They had climbed right to the top of my buy list, and I was ready to swoop the moment I had the cash.
After this morning’s 13.86% jump, Rentokil Initial shares are going to cost a fair bit more than I hoped.
A top recovery play
The stock is on the up after full-year 2023 preliminary results showed adjusted pre-tax profit jumping 43.8% to £766m, with revenues up 44.7% to £5.4bn. Organic revenue growth was 4%, supported by strength in Europe, Asia, Pacific, UK and Latin America. Group adjusted operating margins climbed 120bps to 16.6%.
We learned today that Rentokil has made great strides with its October 2022 acquisition of Terminix for $6.7bn. The board upgraded expectations for total gross cost synergies by $50m to $325m, to be delivered by 2026.
No wonder the shares are flying. The worst thing is, I saw it coming. I’d be feeling like a clever bunny if I’d acted on my instincts and actually bought Rentokil shares, rather than simply praising them.
On November 26, I wrote that markets had been too harsh on the stock after the board warned on 19 October that full-year performance in North America would be “marginally below” previous expectations. The share price crashed 12% in a day. That was despite a 53.3% jump in Q3 revenues to £1.38bn (albeit only by 4.3% on an organic basis).
North America may be the world’s biggest pest control market, but Rentokil has a broad global footprint, and its European and emerging markets operations were still cleaning up.
I accepted that Rentokil shares were priced for growth trading at more than 21 times earnings. When hopes are high, a little bit of bad news can have an outsized impact. Yet I also said it was a top buying opportunity.
Next time I need to take action
On 18 February, I returned to Rentokil, and said the outlook was brightening as the US economy holds up better than expected. Today, CEO Andy Ransom said Rentokil had “created a clear and comprehensive roadmap to reinvigorate growth in North America”. Organic revenue grew 3.1% although there’s a way to go amid “lower new business lead generation”.
Even after today’s jump, the shares are still down 16.21% over the last 12 months, so maybe it isn’t too late to buy them.
They’re still relatively expensive trading at 20.08 times earnings, twice the FTSE 100 average. The yield is just 1.55%, but the board is progressive. It lifted its dividend per share by 15% to 8.68p today, as free cash flow rose 33.7% to £500m.
I wouldn’t buy Rentokil after this morning’s leap. There’s likely to be a bit of profit taking, so I’ll probably bank an instant loss. Instead, I’ll keep a watching brief, wait for things to settle, and purchase it when I have the cash.
I feel gratified that I called the Rentokil share price recovery. Next time, I need to have the courage of my convictions and push that buy button.
The post The Rentokil share price has rocketed 13.86% today! Here’s what I’m doing appeared first on The Motley Fool UK.
Like buying £1 for 51p
This seems ridiculous, but we almost never see shares looking this cheap. Yet this recent ‘Best Buy Now’ has a price/book ratio of 0.51. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 51p they invest!
Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.
What’s more, it currently boasts a stellar dividend yield of around 8.5%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?
See the full investment case
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);
})()
More reading
A bull run is coming! I’ll invest £5k in 5 shares before the stock market rally
Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
